Trial expected to screen more than 1900 early-stage breast cancer patients at 120+ sites in 12 countries across Europe, commencing in Q4 2023 Study will evaluate whether elacestrant can delay occurrence of metastasis or death compared to standard adjuvant endocrine therapy in early-stage…